Effect of dehydroepiandrosterone (DHEA) treatment on oxidative energy metabolism in rat liver and brain mitochondria. A dose-response study

Clinical Biochemistry

Volumn 40, Issue 1-2, 2007, Pages 57-65

  Patel, Minal A ^a   Katyare, Surendra S ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

ATPase activity; Cytochromes; Dehydroepiandrosterone (DHEA); Dehydrogenases; Oxidative energy metabolism

Indexed keywords

CYTOCHROME B; CYTOCHROME C OXIDASE; GLUTAMATE DEHYDROGENASE; OXIDOREDUCTASE; PRASTERONE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); SUCCINIC ACID;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; BREATHING RATE; CONTROLLED STUDY; DRUG EFFECT; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; LIVER MITOCHONDRION; MALE; NONHUMAN; OXIDATION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATASES; ANIMALS; ASCORBIC ACID; BRAIN; CYTOCHROMES; CYTOSOL; DEHYDROEPIANDROSTERONE; GLUTAMIC ACID; MALATES; MALE; MITOCHONDRIA; MITOCHONDRIA, LIVER; OXIDATIVE PHOSPHORYLATION; OXIDOREDUCTASES; PYRUVIC ACID; RATS; SUBSTRATE SPECIFICITY; SUCCINIC ACID; TETRAMETHYLPHENYLENEDIAMINE;

EID: 33845765325     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.08.014     Document Type: Article

References (38)

1. Milgrom E. In: Baulieu E.E., and Kelly P.A. (Eds). Steroid hormone in Hormones: From Molecules to Disease (1990), Hermann Publishers and Hall, New York and London 387-438
2. Buvat J. Androgen therapy with dehydroepiandrosterone. World J. Urol. 21 (2003) 346-355
3. Hinson J.P., and Raven P.W. DHEA deficiency syndrome: a new term for old age?. J. Endocrinol. 163 (1999) 1-5
4. Parker Jr. C.R. Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids 64 (1999) 640-647
5. Celec P., and Starka L. Dehydroepiandrosterone-Is the fountain of youth drying out?. Physiol. Res. 52 (2003) 397-407
6. Oliver T.W., and Clemens K. Action of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res. Rev. 30 (1999) 264-288
7. Swiercynski J., Slominska E., Smolenski R.T., and Mayer D. Increase in NAD but not ATP and GTP concentration in rat liver by dehydroepiandrosterone feeding. Pol. J. Pharmacol. 53 (2001) 125-130
8. Min Kyung H.S., Grieco D., Edward J.R., and Nikodem V.M. Thyroid hormone-mediated transcriptional activation of the rat liver malic enzyme gene by dehydroepiandrosterone. J. Biol. Chem. 64 (1989) 18981-18985
9. Bellei M., Battelli D., Fornieri C., Mori G., Muscatello U., Lardy H., et al. Changes in liver structure and function after short-term and long-term treatment of rats with dehydroisoandrosterone. J. Nutr. 122 (1992) 967-976
10. Abdulkadir Y., Metehan G., Sebahattim D., NuriSahin Y., and Akcay F. Dehydroepiandrosterone improves hepatic antioxidant systems after renal ischemia-reperfusion injury in rabbits. Ann. Clin. Lab. Sci. 33 (2003) 459-464
11. Hoffman S.W., Virmani S., Simkins R.M., and Stine D.G. The delayed administration of dehydroepiandrosterone sulfate improves recovery of function after traumatic brain injury in rats. J. Neurotrauma. 20 (2003) 859-870
12. Lei Z., Bing L., Wu M., Barker J.L., Yoong H.C., Weiqin Z., et al. Dehydroepiandrosterone (DHEA) and its sulfated derivative (DHEAS) regulate apoptosis during neurogenesis by triggering the Akt signaling pathway in opposing ways. Mol. Brain Res. 98 (2002) 58-66
13. Karishma K.K., and Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur. J. Neurosci. 16 (2002) 445-453
14. Su C.Y., and Lardy H. Induction of hepatic mitochondrial glycerophosphate dehydrogenase in rats by dehydroepiandrosterone. J. Biochem. (Tokyo) 110 (1991) 207-213
15. Katyare S.S., Balasubramanian S., and Parmar D.V. Effect of corticosterone treatment on oxidative energy metabolism in developing rat brain. Exp. Neurol. 183 (2003) 241-248
16. Pandya J.D., Agarwal N.A., and Katyare S.S. Effect of dexamethasone treatment on oxidative energy metabolism in rat liver mitochondria during postnatal developmental periods. Drug Chem. Toxicol. 27 (2004) 389-403
17. Swegert C.V., Dave K.R., and Katyare S.S. Effect of aluminum-induced Alzheimer like condition on oxidative energy metabolism in rat liver, brain and heart mitochondria. Mech. Ageing Dev. 12 (1999) 27-42
18. Katewa S.D., and Katyare S.S. Treatment with antimalarials adversely affects the oxidative energy metabolism in rat liver mitochondria. Drug Chem. Toxicol. 27 (2004) 41-53
19. Bangur C.S., Howland J.L., and Katyare S.S. Thyroid hormone treatment alters phospholipid composition and membrane fluidity of the rat brain mitochondria. J. Biochem. 305 (1995) 29-32
20. Satav J.G., Katyare S.S., Fatterpaker P., and Sreenivasan A. Further characterization of rat liver mitochondria fractions. Lipid composition and synthesis, and protein profiles. Biochem. J. 150 (1976) 215-223
21. Ferreira J., and Gil L. Nutritional effects on mitochondrial bioenergetics: alterations in oxidative phosphorylation by rat liver mitochondria. Biochem. J. 218 (1984) 61-67
22. Katyare S.S., and Satav J.G. Impaired mitochondrial energy metabolism following paracetamol-induced hepatotoxicity in the rat. Br. J. Pharmacol. 96 (1989) 51-58
23. Subramaniam M., and Katyare S.S. Oxidative phosphorylation in mouse liver mitochondria during weaning. Mech. Ageing Dev. 54 (1990) 121-129
24. Katewa S.D., and Katyare S.S. A simplified method for inorganic phosphate determination and its application for phosphate analysis in enzyme assays. Anal. Biochem. 323 (2003) 180-187
25. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folin-phenol reagent. J. Biol. Chem. 193 (1951) 265-272
26. Belisle S., Schiff I., and Tulchinsky D. The use of constant infusion of unlabeled dehydroepiandrosterone for the assessment of its metabolic clearance rate, its half-life, and its conversion into estrogens. J. Clin. Endocrinol. Metab. 50 (1980) 117-121
27. Tagawa N., Tamanaka J., Fujinami A., Yoshiharu K., Toru T., Shuji F., Kanji K., Hisato T., and Nobuyuki A. Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism. Clin. Chem. 46 (2000) 523-528
28. Natawa H., Toshihiko Y., Kiminobu G., and Taijiro O.K.A. Mechanism of action of anti-aging DHEA-S and the replacement of DHEA-S. Mech. Ageing Dev. 123 (2002) 1101-1106
29. McIntosh M.K., Pan J.S., and Berdanier C.D. In vitro studies on the effects of dehydroisoandrosterone and corticosterone on hepatic steroid receptor binding and mitochondrial respiration. Comp. Biochem. Physiol. Comp. Physiol. 104 (1993) 147-153
30. Chance D.S., and McIntosh M.K. Hypolipidemic agents after hepatic mitochondrial respiration in vitro. Comp. Biochem. Physiol. C. Pharmacol. Toxicol. Endocrinol. 111 (1995) 317-323
31. Zheng J., and Ramirez V.D. Rapid inhibition of rat brain mitochondrial proton FoF1-ATPase activity by estrogens: comparison with Na+, K+-ATPase of porcine cortex. Eur. J. Pharmacol. 368 (1999) 95-102
32. Lardy H., Marwah A., and Marwah P. Transformations of DHEA and its metabolites by rat liver. Lipids 37 (2002) 1187-1191
33. Steckelbroeck S., Watzka M., Lutjohall D., Makiola P., Nassen A., Hans V.H., et al. Characterization of the dehydroepiandrosterone (DHEA) metabolism via oxysterol 7 alpha-hydroxylase and 17-ketosteroid reductase activity in human brain. J. Neurochem. 83 (2002) 713-726
34. Weill-Engerer S., David J.P., Sazdovitch V., Liere P., Schumacher M., Delacourte A., et al. In vitro metabolism of dehydroepiandrosterone (DHEA) to 7 alpha-hyroxy-DHEA and Delta 5 androstene 3 beta, 17 beta-diol in specific regions of the aging brain from Alzheimer's and non-demented patients. Brain Res. 969 (2003) 117-125
35. Poyton R.O., and Mc Ewen J.E. Crosstalk between nuclear and mitochondrial genomes. Annu. Rev. Biochem. 65 (1996) 563-607
36. Demonacos C., Djordjevic-Mareovic R., Taswdaroglou N., and Sekeris C.E. The mitochondrion is a primary site of action of glucocorticoids: the interaction of glucocorticoids receptor with mitochondrial DNA sequence showing partial similarity to the nuclear glucocorticoid responsive elements. Steroids 55 (1995) 43-55
37. Tsiriyotis C., Sandidos D.A., and Sekeris C.E. The mitochondrion is a primary site of action of glucocorticoids: mitochondrial nucleotide sequences, showing similarity to hormone response elements, confer dexamethasone inducibility to chimaeric genes transfected in LATK-cells. Biochem. Biophys. Res. Commum. 235 (1997) 349-354
38. Simon N., Jolliet P., Moric C., Zini R., Urien S., and Tillement J.P. Glucocorticoids decrease cytochrome c oxidase activity of isolated rat kidney mitochondria. FEBS Lett. 435 (1998) 25-28